how to give semaglutide injection Prescribing Information Higher dose of semaglutide increases

Reflecting on the clinical implications, St-Pierre says that the findings support cautious use of GLP-1 RAs in selected patients with IBD when prescribed for approved metabolic indications, with appropriate counselling and monitoring. At the same time, she noted that the findings highlight substantial evidence gaps and believes future research should move beyond proxy outcomes and incorporate prospective, IBD-specific designs that integrate objective inflammatory measures with robust metabolic phenotyping. Moreover, there should be special considerations on the effects of GLP-1 RAs on body composition of patients with IBD, she adds

They reduce hyperglycemia by inhibiting the reabsorption of glucose from the proximal tubule of the kidney, leading to urinary glucose excretion

Basavappa, R

Store sealed, lyophilized peptides protected from light and humidity at -4F or colder